QurAlis

QurAlis

MA - Cambridge
Biotechnology

Focus: ALS cure - Small Molecules, ASO

QurAlis is a life sciences company focused on ALS cure - Small Molecules, ASO.

Neurology
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

Clinical Trials (1)
NCT06714396A Study Exploring the PK/PD Relationship of QRL-101 in Adults With ALS
Phase 1
Phase 1
Clinical Trials (1)
NCT06532396A Study Evaluating Multiple Ascending Doses of QRL-101 in Healthy Participants
Phase 1
Clinical Trials (1)
NCT07421778A Multiple Ascending Dose Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants
Phase 1
Multiple ascending doses of QRL-201
Amyotrophic Lateral Sclerosis
Phase 1
Clinical Trials (1)
NCT05633459A Study Evaluating the Safety and Tolerability of QRL-201 in ALS
Phase 1
QRL-101 Dose A
Healthy
Phase 1
Clinical Trials (1)
NCT06681441A 3-way Cross-over Study on the Effects of QRL-101 on Transcranial Magnetic Stimulation and Nerve Excitability in Healthy Participants
Phase 1
Phase 1
Clinical Trials (1)
NCT05667779A Study Evaluating Safety, Tolerability, and Pharmacokinetics of QRL-101 in Healthy Participants
Phase 1
Phase 1
Clinical Trials (1)
NCT06877624A Study Evaluating the Pharmacokinetics of Three QRL-101 Formulations in Healthy Participants
Phase 1

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 7 clinical trials